🇺🇸 FDA
Patent

US 9889081

Aldehyde dehydrogenase inhibitors as novel depigmenting agents

granted A61KA61K31/145A61K31/16

Quick answer

US patent 9889081 (Aldehyde dehydrogenase inhibitors as novel depigmenting agents) held by The Board of Regents of the University of Texas System expires Mon Feb 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Feb 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/145, A61K31/16, A61K31/26, A61K31/27